Bernal-Rusiel, JL, Greve, DN, Reuter, M., Fischl, B. & Sabuncu, MR Statistical analysis of longitudinal neuroimage data with linear mixed-effects models. Neuroimaging 66249-260 (2013).
Cespedes, MI et al. Comparisons of neurodegeneration over time between healthy aging and Alzheimer’s disease cohorts via Bayesian inference. BMJ open sevene012174 (2017).
Ziegler, G., Penny, WD, Ridgway, GR, Ourselin, S. & Friston, KJ Estimation of anatomical trajectories with Bayesian mixed effects modeling. Neuroimaging 12151–68 (2015).
Bliese, PD Intra-group agreement, non-independence and reliability: implications for data aggregation and analysis (OpenScience, 2000).
Guerrero, R. et al. Instantiated modeling of the mixed effects of Alzheimer’s disease markers. Neuroimaging 142113–125 (2016).
Rivera-Lares, K., Logie, R., Baddeley, A. & Della Sala, S. The rate of forgetting is independent of the initial degree of learning. Same. To know. https://doi.org/10.3758/s13421-021-01271-1 (2022).
Kieser, M., Friede, T. & Gondan, M. Assessing statistical significance and clinical relevance. Med Statistics 321707-1719 (2013).
Van Rijn, MHC, Bech, A., Bouyer, J., and Van Den Brand, JAJG Statistical significance versus clinical relevance. Nephrol. Dial. Transplant. 326–12 (2017).
Aksman, LM et al. Longitudinal imaging biomarker modeling with multi-task Bayesian parametric learning. Hmm. Brain mapping. 403982–4000 (2019).
Interim, AGM et al. How Bayesian statistics can help answer some of the controversial questions in clinical research on Alzheimer’s disease. Alzheimer’s dementia. 17917–919 (2021).
Lesaffre, E. & Lawson, AB Bayesian biostatistics (Wiley, 2012).
Wilkinson, M. Distinguishing between statistical significance and practical/clinical significance using statistical inference. Med. athletic. 44295–301 (2014).
Hespanhol, L., Vallio, CS, Costa, LM & Saragiotto, BT Understanding and interpreting confidence and credibility intervals around effect estimates. Bras. J.Phys. The. 23290-301 (2019).
Berry, DA Bayesian clinical trials. Nat. Rev. Drug Discov. 527–36 (2006).
Gurrin, LC, Kurinczuk, JJ & Burton, PR Bayesian Statistics in Medical Research: An Intuitive Alternative to Conventional Data Analysis. J. Eval. Clin. Practice. 6193–204 (2000).
van de Schoot, R., Winter, SD, Ryan, O., Zondervan-Zwijnenburg, M. & Depaoli, S. A systematic review of Bayesian papers in psychology: The past 25 years. Psychol. Methods 22217-239 (2017).
Wagenmakers, EJ et al. Bayesian inference for psychology. Part I: Theoretical benefits and practical ramifications. Psychone. Bull. Round. 2535–57 (2018).
Jack, CR et al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Neurol lancet. 12207-216 (2013).
Hardy, J. Amyloid, presenilins and Alzheimer’s disease. Neuroscience Trends. 20154-159 (1997).
Jack, CR et al. NIA-AA research framework: Towards a biological definition of Alzheimer’s disease. Alzheimer’s dementia. 14535–562 (2018).
Petersen, RC et al. Alzheimer’s Disease Neuroimaging Initiative (ADNI): Clinical Characterization. Neurology 74201-209 (2010).
Caroli, A. & Frisoni, GB The dynamics of Alzheimer’s disease biomarkers in the Alzheimer’s Disease Neuroimaging Initiative cohort. Neurobiol. Aging 311263-1274 (2010).
Dickerson, BC et al. MRI-derived entorhinal and hippocampal atrophy in incipient, very mild Alzheimer’s disease. Neurobiol. Aging 22747–754 (2001).
Jack, CR et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 55484–489 (2000).
Schuff, N. et al. MRI of hippocampal volume loss in early Alzheimer’s disease in relation to ApoE genotype and biomarkers. Brain 1321067-1077 (2009).
Zhang, L. et al. Longitudinal trajectory of amyloid-related hippocampal subfield atrophy in nondemented elderly people. Hmm. Brain mapping. 412037-2047 (2020).
Reuter, M., Schmansky, NJ, Rosas, HD & Fischl, B. Within-subject model estimation for unbiased longitudinal image analysis. Neuroimaging 611402-1418 (2012).
Landau, S. & Jagust, W. Methods of treatment of florbetapir (2015).
Buckner, RL et al. A Unified Approach for Analyzing Morphometric and Functional Data in Young, Older, and Demented Adults Using Automated Atlas-Based Head Size Normalization: Reliability and Validation Against Manual Measurement of Head Size total intracranial volume. Neuroimaging 23724–738 (2004).
Jack, CR et al. Rates of atrophy accelerate in amnesic mild cognitive impairment. Neurology 701740–1752 (2008).
Fitzmaurice, GM, Laird, NM & Ware, JH Applied Longitudinal Analysis (Wiley, 2011).
Satterthwaite, FE An approximate distribution of variance component estimates. Biometer. Bull. 2110 (1946).
Morey, RD, Hoekstra, R., Rouder, JN, Lee, MD & Wagenmakers, EJ The error of placing confidence in confidence intervals. Psychone. Bull. Round. 23103-123 (2016).
Bates, D., Mächler, M., Bolker, B., and Walker, S. Fitting linear mixed-effects models using lme4. J. Stat. Software 67201–210 (2015).
Team, SD Rstan: the R interface to Sta (2020).
Sorensen, T., Hohenstein, S. & Vasishth, S. Bayesian Linear Mixed Models Using Stan: A Tutorial for Psychologists, Linguists, and Cognitive Scientists. As to. Psychol methods. 12175-200 (2015).
Hubbard, R. Corrupt research: the case for reconceptualizing empirical management and the social sciences (SAGE, 2016). https://doi.org/10.4135/9781506305332.
Ziliak, S. & McCloskey, D. The cult of statistical significance: How standard error is costing us jobs, justice and lives (University of Michigan Press, 2008).
Pocock, SJ & Hughes, MD Estimation issues in clinical trials and insights. Med Statistics 9657–671 (1990).
Lid. et al. Bayesian joint-latent-time mixed-effects model of progression in the Alzheimer’s disease neuroimaging initiative. Alzheimer’s dementia. Diag. Assess. Say. Monit. ten657–668 (2018).
Staffaroni, AM et al. Longitudinal multimodal imaging and clinical parameters for frontotemporal dementia clinical trials. Brain 142443–459 (2019).
McKhann, Managing Director et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the working groups of the National Institute on Aging and the Alzheimer’s Association on guidelines for the diagnosis of Alzheimer’s disease. Alzheimer’s dementia. seven263-269 (2011).
Albert, MS et al. Diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the working groups of the National Institute on Aging and the Alzheimer’s Association on guidelines for the diagnosis of Alzheimer’s disease. Alzheimer’s dementia. seven270-279 (2011).